🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the persistence of antibodies against hepatitis B at 30, 42, 54...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-04-21
Trial ID
NCT00343915
Treatments Being Tested
In this study, subjects who received primary neonatal vaccination with hepa...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-04
Trial ID
NCT00657657
Treatments Being Tested
The purpose of the present trial is to evaluate 6 vaccine formulations of r...
Status
Completed
Location
GSK Clinical Trials Call Center
Start Date
1993-11
Trial ID
NCT00697970
Treatments Being Tested
This study will evaluate the persistence of immunity to hepatitis B 10 to 1...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-07
Trial ID
NCT01138098
Treatments Being Tested
The main aim of this vaccine is to prevent cervical cancer in women. Howeve...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-04-05
Trial ID
NCT00309166
Treatments Being Tested
The purpose of this study is to determine the durability of seroprotection ...
Status
Completed
Location
Clinical Research Associates of Tidewater
Start Date
2010-12
Trial ID
NCT01282762
The purpose of this study is to document the immunological response to the ...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00362336
Treatments Being Tested
Only subjects who participated in the primary study will be invited to part...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-05-26
Trial ID
NCT00684671
The current study will evaluate immunological memory to hepatitis B antigen...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04
Trial ID
NCT00456625
Treatments Being Tested
To demonstrate that the immune response to hepatitis B antigen of the DTaP-...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00315055
Treatments Being Tested